Delivery Order 75N93023D00015-75N93023F00001
Award Date 6/20/23
Potential Completion Date 6/19/30
Potential Value $3.5K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $2,696,523.00 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer, for NIAID's Preclinical Development Support program. The contract has a period of performance through December 31, 2026 and is a cost-plus-fixed-fee type. ABL, a leading contract research and manufacturing organization, provides a range of preclinical and clinical development services to support...
- This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL). The contract is for $1,812,395.46 and provides for the manufacture and characterization of vaccines and other biologics. The contract does not have a set-aside designation. ABL is a foreign-owned, for-profit organization that specializes in the development of gene...
- This is a definitive, cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods. The contract, valued at $213,045,738.00, is for preclinical development services to support infectious disease research and product development initiatives. The contract does not have a set-aside designation. ABL has been awarded numerous federal contracts and grants,...
- This federal contract award is to Advanced Bioscience Laboratories, Inc. (ABL) from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services. The contract is for the performance of toxicity testing for HIV proteins as part of NIAID's Preclinical Development Support program. The contract is a cost-plus-fixed-fee delivery order with a ceiling value of $1,050,558.51 and a period of performance through April 7, 2017....
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $173,773 award is for a base task order under a larger Indefinite Delivery Vehicle (IDV) valued at $534,190.43. The contract is for the manufacture and characterization of vaccines, with a period of performance ending on May 14, 2028. The contract is cost-plus-fixed-fee and does not...
- This is a prime contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL) on September 20, 2017. The contract has a potential value of $2,044,103.00 and is a Delivery Order for NIAID Preclinical Development Support services. The contract has a completion date of December 31, 2022 and is not set-aside. ABL is a contract research and...
- This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), a civilian federal agency. The contract, valued at $4,328,663.00, is for expertise in the product development lifecycle, including services such as cGMP manufacturing of vaccines and biologics, process development, analytical testing, stability studies, and project management for infectious...
- This federal contract award, valued at $229,136.49, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL). The contract is for ABL to assist NIAID in planning and implementing two separate meetings focused on potential ways to leverage private sector partnerships for pediatric formulation development. This contract is a delivery order under the larger "HIV...
- This is a $6,095,159.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL) for expertise in professional pharmaceutical project management. The contract is issued under the larger Resources to Advance Pediatrics and HIV Prevention Science indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. ABL, a manufacturer of biologics including vaccines and monoclonal antibodies,...
- This federal contract award, valued at $462,454.57, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer. The contract is a Delivery Order under the Simian Vaccine Evaluation Units 2013-2020 Indefinite Delivery Vehicle (IDV), and the work involves providing administrative and technical support for ongoing Task Area 3 studies and final transition. The contract does not have...